Cyclana Bio Oct 21 2025 Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women's health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, Wilbe, and Angel investors. The investment will enable Cyclana Bio to develop functional disease models and its platform, dedicated to revolutionising women's health through tissue level therapeutics, starting with the discovery of treatments for endometriosis. Endometriosis